# US 2004/0204489 A1 · Method of treating a swollen gland curing cancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0204489 A1
- Document ID: US20040204489A1
- Status: Published application
- Kind: A1
- Application number: 10/414,140
- Filed: 2003-04-14
- Published: 2004-10-14
- Earliest claimed: 2003-04-14
- Inventors: Arthur Vanmoor
- Web page: https://patentgrep.com/patent/US20040204489A1

## CPC

- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/195: having an amino group
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

There is disclosed a method of treating a swollen gland in a person in need of such treatment, which comprises the administration to such person of an effective amount of at least one compound represented by formula (I) X—CH2—CH(OY)1-p(H)pCH(NH2+)pCOO− (I) wherein X represents a trimethylammonio group (CH3)3N+ or a carbamoyl group (CONH2), Y is hydrogen or an acetyl (CH3CO) group, and p is zero or one, provided that when X is a carbamoyl group p is one, and when X is a trimethylammonio group p is zero.

## Claims

### Claim 1

A method of treating a person suffering from a swelling of a gland which comprises the administration to such person of an effective amount of at least one compound represented by formula (I)
X—CH2—CH(OY)1-p(H)pCH(NH2+)pCOO31 (I)
wherein X represents a trimethylammonio group (CH3)3N+ or a carbamoyl group (CONH2), Y is hydrogen or an acetyl (CH3CO) group, and p is zero or one, provided that when X is a carbamoyl group p is one, and when X is a trimethylammonio group p is zero.

### Claim 2 (depends on 1)

The method of claim 1, wherein the compound is administered orally with food.

### Claim 3 (depends on 1)

The method of claim 1, wherein the compound is administered by injection into the bloodstream.

### Claim 4 (depends on 1)

The method of claim 1, wherein the compound is administered by rectal suppository.

### Claim 5 (depends on 1)

The method of claim 1, wherein the effective amount of the compound is administered in one to five daily doses, each dose being in the range of 2 to 20 gram.

### Claim 6 (depends on 1)

The method of claim 1, wherein the total of said effective amount of the compound administered daily is in the range of 2 to 100 grams.

### Claim 7 (depends on 6)

The method of claim 6, wherein the total of said effective amount of the compound administered daily is in the range of 20 to 50 grams.

### Claim 8 (depends on 1)

The method of claim 1, wherein said person experiences reduction in the size of the swelling.

### Claim 9 (depends on 1)

The method of claim 1 wherein after treatment the size of the gland has returned to normal.

### Claim 10 (depends on 1)

The method of claim 1 wherein the compound is
H2NCO—CH2—CH2−CH(NH2+)COO−

### Claim 11 (depends on 1)

The method of claim 1 wherein the compound is
(CH3)3N+-CH2—CH(OH)CH2COO−

### Claim 12 (depends on 1)

The method of claim 1 wherein the compound is
(CH3)3N+-CH2—CH(OCOCH3)CH2COO−

### Claim 13 (depends on 1)

The method of claim 1, wherein a plurality of compounds represented by formula (I) is administered.

### Claim 14 (depends on 1)

The method of claim 1 wherein the gland is a sweat gland.

### Claim 15 (depends on 1)

The method of claim 1, wherein the gland is a sebaceous gland.

### Claim 16 (depends on 1)

The method of claim 1, wherein the gland is an endocrine gland.

### Claim 17 (depends on 1)

The method of claim 1, wherein the gland is selected from the group consisting of the liver, the gall bladder, the kidney, and the salivary gland.

### Claim 18

A method of treating a person suffering from a swelling of a gland which comprises enhancing the person's immune system by the administration to such person of an effective amount of at least one compound represented by formula (I)
X—CH2—CH(OY)1-p(H)pCH(NH2+)pCOO− (I)
wherein X represents a trimethylammonio group (CH3)3N+ or a carbamoyl group (CONH2), Y is hydrogen or an acetyl (CH3CO) group, and p is zero or one, provided that when X is a carbamoyl group p is one, and when X is a trimethylammonio group p is zero.

### Claim 19 (depends on 18)

The method of claim 18, wherein the gland is a sweat gland.

### Claim 20 (depends on 18)

The method of claim 18, wherein the gland is a sebaceous gland.
